An epistatic interaction controls the latency of a transgene-induced mammary tumor

Mammalian Genome

Volumn 11, Issue 10, 2000, Pages 883-889

  Le Voyer, Thomas ^a   Lu, Zichun ^a   Babb, James ^a   Lifsted, Traci ^a   Williams, Max ^a   Hunter, Kent ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CHROMOSOME 15; CHROMOSOME 9; CONTROLLED STUDY; FEMALE; GENE MAPPING; GENETIC EPISTASIS; GENOTYPE; INBRED STRAIN; LATENT PERIOD; MALE; METASTASIS; MOUSE; NONHUMAN; ONSET AGE; PHENOTYPE; QUANTITATIVE TRAIT; TRANSGENE; TUMOR GROWTH;

ANIMALIA;

EID: 0033808727     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003350010163     Document Type: Article

References (37)

1. Allelic loss of chromosomal arm 8p in breast cancer progression
2. Familial risk, abortion and their interactive effect on the risk of breast cancer - A combined analysis of six case-control studies
3. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer
4. Genetic alterations in breast cancer
5. A genetic map of the mouse suitable for typing intraspecific crosses
6. Permutation tests for multiple loci affecting a quantitative character
7. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. The Breast Cancer Linkage Consortium
8. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
9. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
10. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
11. Taking stock of complex trait genetics in mice
12. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185de1AG in Ashkenazi Jewish families
13. A large kindred with 17q-linked breast and ovarian cancer: Genetic, phenotypic, and genealogical analysis
14. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
15. Hormones and breast cancer
16. Epidemiologic analysis of breast and gynecologic cancers
17. Estrogen receptor expression in benign breast epithelium and breast cancer risk
18. A rare CYP19 (aromatase) variant may increase the risk of breast cancer
19. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus
20. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
21. BRCA1 mutations in a population-based sample of young women with breast cancer
22. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
23. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression
24. Overview of QTL mapping software and introduction to map manager QT
25. Isolation of BRCA1, the 17q-linked breast and ovarian cancer susceptibility gene
26. Familial breast-ovarian cancer locus on chromosome 17q12-q23
27. Risk modifiers in carriers of BRCA1 mutations
28. Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families
29. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus
30. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene
31. Strain differences in response of the mouse mammary gland to hormones in vitro
32. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
33. Population genetics of BRCA1 and BRCA2
34. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
35. Effect of endogenous and exogenous hormones on breast cancer: Epidemiology
36. Identification of the breast cancer susceptibility gene BRCA2